IOTA Pharmaceuticals
St Johns Innovation Centre
Cowley Road
Cambridge
CB4 0WS
United Kingdom
Tel: 44-0-1223-421430
Fax: 44-0-1223-421430
Website: http://www.iotapharma.com/
Email: info@iotapharma.com
6 articles about IOTA Pharmaceuticals
-
Astellas Pharma is building on a 2019 collaborative relationship and snapping up California-based iota Biosciences and that company’s bioelectronics technology in order to accelerate its Rx+ business.
-
IOTA and MassGen Hospital Establish PHOENIX, an Open-access Preclinical Glioblastoma Drug Screening Pipeline
11/20/2019
IOTA Pharmaceuticals Ltd and the Experimental Therapeutic Unit of the Neurology Department of Massachusetts General Hospital announced the creation of a new Glioblastoma drug screening pipeline, PHOENIX™.
-
IOTA Pharmaceuticals Announce the Creation of a Glioblastoma Drug Bank to Support and Accelerate New Research Into Brain Cancer Therapy
5/23/2018
IOTA Pharmaceuticals Ltd today announced the creation of a new resource, the Glioblastoma (GBM) Drug Bank, to accelerate drug discovery research in brain cancer, especially glioblastoma.
-
IOTA Pharmaceuticals, KinaseDetect and SARomics Biostructures Announce the Formation of the KINOMED Partnership to Accelerate Human Protein Kinase Drug Discovery
2/22/2011
-
New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals and Beactica AB
4/23/2008
-
Establishment of IOTA Pharmaceuticals, a new Fragment-based Drug Discovery Company
9/25/2007